Concourse Financial Group Securities, Inc. Repligen Corp Transaction History

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024

A detailed history of Concourse Financial Group Securities, Inc. transactions in Repligen Corp stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 345 shares of RGEN stock, worth $50,625. This represents 0.0% of its overall portfolio holdings.

Number of Shares
345
Previous 350 1.43%
Holding current value
$50,625
Previous $44,000 15.91%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024
SELL
$119.79 - $167.35 $598 - $836
-5 Reduced 1.43%
345 $51,000
Q1 2024

Apr 30, 2024
SELL
$170.78 - $208.42 $170 - $208
-1 Reduced 0.28%
350 $64,000
Q4 2023

Feb 07, 2024
SELL
$114.17 - $185.35 $1,255 - $2,038
-11 Reduced 3.04%
351 $63,000
Q3 2023

Oct 25, 2023
SELL
$138.78 - $176.51 $1,110 - $1,412
-8 Reduced 2.16%
362 $57,000
Q2 2023

Aug 10, 2023
BUY
$138.42 - $180.31 $9,550 - $12,441
69 Added 22.92%
370 $52,000
Q1 2023

May 15, 2023
SELL
$154.26 - $198.1 $325,334 - $417,792
-2,109 Reduced 87.51%
301 $50,000
Q4 2022

Jan 30, 2023
SELL
$162.42 - $220.56 $5,684 - $7,719
-35 Reduced 1.43%
2,410 $0
Q3 2022

Nov 15, 2022
SELL
$160.42 - $256.21 $16,523 - $26,389
-103 Reduced 4.04%
2,445 $457,000
Q2 2022

Aug 09, 2022
SELL
$140.68 - $188.02 $1,406 - $1,880
-10 Reduced 0.39%
2,548 $414,000
Q1 2022

May 09, 2022
SELL
$161.19 - $257.96 $48,679 - $77,903
-302 Reduced 10.56%
2,558 $481,000
Q4 2021

Feb 07, 2022
BUY
$247.59 - $304.47 $7,922 - $9,743
32 Added 1.13%
2,860 $757,000
Q3 2021

Nov 09, 2021
BUY
$194.77 - $324.21 $456,346 - $759,624
2,343 Added 483.09%
2,828 $817,000
Q2 2021

Aug 13, 2021
BUY
$165.87 - $220.95 $663 - $883
4 Added 0.83%
485 $96,000
Q1 2021

May 13, 2021
SELL
$180.37 - $226.26 $14,068 - $17,648
-78 Reduced 13.95%
481 $94,000
Q4 2020

Feb 02, 2021
BUY
$148.08 - $206.57 $82,776 - $115,472
559 New
559 $107,000
Q3 2020

Nov 13, 2020
BUY
$122.51 - $158.27 $0 - $0
0 New
0 $0
Q2 2020

Aug 13, 2020
SELL
$94.33 - $140.48 $1,792 - $2,669
-19 Closed
0 $0
Q1 2020

May 13, 2020
SELL
$84.96 - $109.14 $679 - $873
-8 Reduced 29.63%
19 $2,000
Q4 2019

Feb 14, 2020
BUY
$73.84 - $93.08 $1,993 - $2,513
27 New
27 $2,000
Q3 2019

Nov 13, 2019
SELL
$76.65 - $95.51 $3,449 - $4,297
-45 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$49.45 - $62.8 $2,225 - $2,826
45 New
45 $2,000
Q4 2018

Feb 14, 2019
BUY
$48.26 - $68.88 $0 - $0
0 New
0 $0
Q3 2018

Nov 13, 2018
BUY
$46.8 - $58.97 $0 - $0
0 New
0 $0

Others Institutions Holding RGEN

# of Institutions
489
Shares Held
54.3M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.14B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email